Implications of RAS Mutational Status in Subsets of Patients with Newly Diagnosed Acute Myeloid Leukemia (AML) across Therapy Groups
暂无分享,去创建一个
M. Konopleva | M. Andreeff | K. Bhalla | H. Kantarjian | G. Garcia-Manero | T. Kadia | F. Ravandi | Koichi Takahashi | G. Borthakur | E. Jabbour | N. Daver | C. Dinardo | S. Pierce | R. Kanagal-Shamanna | N. Pemmaraju | G. Montalban-Bravo | M. Yilmaz | D. Rivera